Dabigatran for Thromboembolism: Comparative Efficacy and Res
2026-07-30
The reference study reviews the clinical innovation of dabigatran, the first non-vitamin K oral anticoagulant (NOAC) approved for thromboembolic disorders. It highlights dabigatran's predictable pharmacology, reduced monitoring requirements, and favorable safety profile compared to warfarin, with implications for both clinical management and translational research.
Tau Ser356 Phosphorylation, NUAK1 Inhibition, and Alzheimer’
2026-07-29
Taylor et al. (2023) identify tau phosphorylation at serine 356 (p-tau Ser356) as a neuropathological feature closely linked to Alzheimer’s disease (AD) progression and demonstrate that pharmacological inhibition of NUAK1 can selectively decrease p-tau Ser356 in both mouse and human brain tissue. Their findings offer new mechanistic insight into tau pathology and highlight the complexity of translational approaches targeting tau kinases in AD.
n-Dodecyl-β-D-maltoside: Transforming Membrane Protein Purif
2026-07-29
n-Dodecyl-β-D-maltoside (DDM) delivers unmatched performance for solubilizing, stabilizing, and preserving the functional integrity of challenging membrane proteins like WecA. Learn how to leverage DDM for robust workflows, enhanced yields, and reproducible results, informed by cutting-edge research and advanced troubleshooting strategies.
Z-VEID-FMK: Precision Caspase-6 Inhibitor for Apoptosis Assa
2026-07-28
Z-VEID-FMK empowers researchers to dissect caspase-6-dependent apoptosis in neuronal and inflammatory pain models with robust specificity. This advanced, irreversible caspase-6 inhibitor streamlines experimental workflows and delivers reproducible, high-clarity results even in complex cellular contexts.
Salvianolic Acid A Targets GOT2 to Protect Against Doxorubic
2026-07-28
This study uncovers how salvianolic acid A (SAA) mitigates doxorubicin-induced myocardial oxidative injury by targeting glutamic-oxaloacetic transaminase 2 (GOT2) and enhancing the malate-aspartate NADH shuttle. The findings highlight a mechanistically distinct cardioprotective strategy and provide a valuable model for oxidative stress assay workflows.
Exogenous NADH Enhances Aminoglycoside Action in E. tarda
2026-07-27
This study demonstrates that exogenous NADH reprograms the metabolism of multidrug-resistant Edwardsiella tarda, significantly enhancing the bactericidal effect of aminoglycoside antibiotics. The findings highlight a promising metabolic intervention strategy to address antibiotic resistance in clinical and aquaculture settings.
tFUS Mitigates Stroke Neuroinflammation via Nespas/miR-383-3
2026-07-27
This study demonstrates that transcranial focused ultrasound stimulation (tFUS) reduces NLRP3-driven neuroinflammation after ischemic stroke by modulating the Nespas/miR-383-3p/SHP2 axis in microglia. The findings provide mechanistic insight into tFUS as a neuroprotective intervention and identify SHP2 as a critical molecular target for post-stroke inflammatory regulation.
Cefepime (BMY-28142): Optimizing CNS Infection Research Prot
2026-07-26
Cefepime (BMY-28142) enables advanced modeling of central nervous system infections due to its ability to cross the blood-brain barrier and broad antimicrobial spectrum. This article delivers actionable protocol enhancements, comparative insights, and troubleshooting guidance for research teams tackling Gram-positive and Gram-negative pathogens.
HyperScribe T7 High Yield RNA Synthesis Kit Plus for mRNA Re
2026-07-25
The HyperScribe T7 High Yield RNA Synthesis Kit Plus empowers researchers with rapid, high-yield in vitro transcription for mRNA intervention and advanced genetic studies. Its robust protocol flexibility and high capacity for custom-capped, labeled, or biotinylated RNA make it a standout for translational workflows including novel mRNA rescue strategies.
Sulforaphane Inhibits NLRP3 Inflammasome in Ulcerative Colit
2026-07-24
This study demonstrates that sulforaphane, a natural isothiocyanate, significantly decreases oxidative stress and suppresses NLRP3 inflammasome activation in a mouse model of ulcerative colitis. These findings clarify sulforaphane’s mechanistic potential for inflammation research and provide validated parameters for preclinical inflammatory bowel disease workflows.
Actin–Myosin II Network’s Role in Duck Enteritis Virus Repli
2026-07-24
This study systematically maps the host protein interactome of the duck enteritis virus VP26 protein, identifying the actin–myosin II cytoskeletal network—particularly MYH9—as essential for viral proliferation. Functional disruption of actin assembly with reversible inhibitors like Latrunculin A significantly impairs DEV replication, highlighting both mechanistic insights and experimental strategies for virology and cell biology research.
SB743921: Potent Kinesin Spindle Protein Inhibitor for Cance
2026-07-23
SB743921 is a highly selective kinesin spindle protein inhibitor that induces mitotic arrest and apoptosis in diverse cancer cell lines. Its nanomolar potency and demonstrated efficacy in tumor xenograft models make it a valuable tool for preclinical cancer research. APExBIO supplies SB743921 under SKU B1590 for research applications.
Negative Feedback of IPA Regulates Auxin Biosynthesis via TA
2026-07-23
This study reveals how indole-3-pyruvic acid (IPA) exerts negative feedback on tryptophan aminotransferase (TAA1), finely tuning the two-step auxin (IAA) biosynthesis pathway in plants. The findings clarify a key regulatory mechanism and offer practical insights for plant hormone and metabolic research.
Prochlorperazine: Mechanistic Advances in Melanoma Research
2026-07-22
Explore the distinctive role of Prochlorperazine as a dopamine D2 receptor antagonist in melanoma research. This article delivers novel assay insights, unpacks recent mechanistic breakthroughs, and sets a new benchmark for scientific rigor beyond standard protocol guides.
Cefepime (BMY-28142): Precision Tools for CNS Infection Rese
2026-07-22
Cefepime (BMY-28142) stands out as a research-grade cephalosporin for modeling antimicrobial resistance and blood-brain barrier penetration in central nervous system infection studies. This article covers advanced workflow strategies, practical troubleshooting, and new insights on resistance mechanisms to optimize your experimental outcomes.
457 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page